Antivirals against the Chikungunya Virus

Chikungunya virus (CHIKV) is a mosquito-transmitted alphavirus that has re-emerged in recent decades, causing large-scale epidemics in many parts of the world. CHIKV infection leads to a febrile disease known as chikungunya fever (CHIKF), which is characterised by severe joint pain and myalgia. As m...

وصف كامل

التفاصيل البيبلوغرافية
الحاوية / القاعدة:	Viruses
المؤلفون الرئيسيون:	Verena Battisti, Ernst Urban, Thierry Langer
التنسيق:	مقال
اللغة:	الإنجليزية
منشور في:	MDPI AG 2021-07-01
الموضوعات:	Chikungunya virus alphavirus antiviral therapy direct-acting antivirals host-directed antivirals in silico screening
الوصول للمادة أونلاين:	https://www.mdpi.com/1999-4915/13/7/1307

مواد مشابهة

Antiviral Strategies against Arthritogenic Alphaviruses
حسب: Rana Abdelnabi, وآخرون
منشور في: (2020-09-01)

Broad-Spectrum Antivirals Derived from Natural Products
حسب: Wen-Jun Tian, وآخرون
منشور في: (2023-04-01)

Nitrogen-Based Heterocyclic Compounds: A Promising Class of Antiviral Agents against Chikungunya Virus
حسب: Andreza C. Santana, وآخرون
منشور في: (2020-12-01)

In-vitro antiviral activity of Carica papaya formulations against dengue virus type 2 and chikungunya virus
حسب: P. Patil, وآخرون
منشور في: (2022-12-01)

Screening Drugs for Broad-Spectrum, Host-Directed Antiviral Activity: Lessons from the Development of Probenecid for COVID-19
حسب: Ralph A. Tripp, وآخرون
منشور في: (2023-11-01)

Explorations on the antiviral potential of zinc and magnesium salts against chikungunya virus: implications for therapeutics
حسب: Kusuma Sai Davuluri, وآخرون
منشور في: (2024-06-01)

Synergistic In Vitro Antiviral Effect of Combinations of Ivermectin, Essential Oils, and 18-(Phthalimid-2-yl)ferruginol against Arboviruses and Herpesvirus
حسب: Liliana Betancur-Galvis, وآخرون
منشور في: (2023-11-01)

4′-Fluorouridine inhibits alphavirus replication and infection in vitro and in vivo
حسب: Peiqi Yin, وآخرون
منشور في: (2024-06-01)

Identification of 2,4-Diaminoquinazoline Derivative as a Potential Small-Molecule Inhibitor against Chikungunya and Ross River Viruses
حسب: Amrita Saha, وآخرون
منشور في: (2023-10-01)

Mayaro Virus: The State-of-the-Art for Antiviral Drug Development
حسب: Ana Paula Andreolla, وآخرون
منشور في: (2022-08-01)

Advancing Viral Defense: Unravelling the Potential of Host-Directed Antivirals Against SARS-CoV-2
حسب: Zheng Yao Low, وآخرون
منشور في: (2025-03-01)

Outcomes of liver transplantation in the era of modern antiviral therapy for hepatitis C
حسب: K. Yu. Kokina, وآخرون
منشور في: (2021-04-01)

Chikungunya and Zika Viruses: Co-Circulation and the Interplay between Viral Proteins and Host Factors
حسب: Sineewanlaya Wichit, وآخرون
منشور في: (2021-04-01)

Direct-Acting Antiviral Agents for Hepatitis C Virus Infection—From Drug Discovery to Successful Implementation in Clinical Practice
حسب: Christopher Dietz, وآخرون
منشور في: (2022-06-01)

Antiviral, Cytoprotective, and Anti-Inflammatory Effect of <i>Ampelozizyphus amazonicus</i> Ducke Ethanolic Wood Extract on Chikungunya Virus Infection
حسب: Daniele C. P. Rocha, وآخرون
منشور في: (2023-11-01)

Hepatitis C Virus and Antiviral Drug Resistance
حسب: Seungtaek Kim, وآخرون
منشور في: (2016-11-01)

A Real-World Analysis of the Population with Hepatitis C Virus Infection Affected by Type 2 Diabetes in Italy: Patients’ Characteristics, Comorbidity Profiles and Treatment Patterns
حسب: Edoardo Giovanni Giannini, وآخرون
منشور في: (2025-03-01)

Repurposing Drugs for Mayaro Virus: Identification of EIDD-1931, Favipiravir and Suramin as Mayaro Virus Inhibitors
حسب: Lana Langendries, وآخرون
منشور في: (2021-03-01)

Efficacy of Direct Acting Antivirals (DAA) therapy in patients with recurrent hepatitis C after liver and kidney transplantation: a cross-sectional study
حسب: Mehdi Kashani, وآخرون
منشور في: (2024-10-01)

Efficacy and safety of direct-acting antivirals for HCV in patients with extrahepatic malignancies: real-life experience
حسب: Mira Atef, وآخرون
منشور في: (2022-09-01)

The Synthetic Peptide GA-Hecate and Its Analogs Inhibit Multiple Steps of the Chikungunya Virus Infection Cycle In Vitro
حسب: Gabriela Miranda Ayusso, وآخرون
منشور في: (2023-09-01)

Hepatitis C: sociodemographic and clinical profile of patients treated with direct-acting antivirals in a pharmaceutical office
حسب: Karem Aline Pegoraro, وآخرون
منشور في: (2023-11-01)

A Review of the Biology of Chikungunya Virus Highlighting the Development of Current Novel Therapeutic and Prevention Approaches
حسب: Geovana Martelossi-Cebinelli, وآخرون
منشور في: (2025-10-01)

Direct-acting Antiviral Agents Resistance-associated Polymorphisms in Chinese Treatment-naÏve Patients Infected with Genotype 1b Hepatitis C Virus
حسب: Ye Wang, وآخرون
منشور في: (2015-01-01)

A validation study of after direct‐acting antivirals recommendation for surveillance score for the development of hepatocellular carcinoma in patients with hepatitis C virus infection who had received direct‐acting antiviral therapy and achieved sustained virological response
حسب: Toshifumi Tada, وآخرون
منشور في: (2022-01-01)

Reporter Replicons for Antiviral Drug Discovery against Positive Single-Stranded RNA Viruses
حسب: Rafaela S. Fernandes, وآخرون
منشور في: (2020-05-01)

Advances in the Development of Small Molecule Antivirals against Equine Encephalitic Viruses
حسب: Tyler J. Ogorek, وآخرون
منشور في: (2023-02-01)

Hepatocellular carcinoma in hepatitis C virus patients treated with direct acting antivirals (DAAs) and patients not exposed to DAAs: a large center comparative study
حسب: Mohamed Elgazzar, وآخرون
منشور في: (2024-05-01)

Antiviral action of aqueous extracts of propolis from Scaptotrigona aff. postica (Hymenoptera; Apidae) against Zica, Chikungunya, and Mayaro virus
حسب: R. Z. Mendonça, وآخرون
منشور في: (2024-07-01)

Chronic Hepatitis C Treatment with New Antiviral Agents
حسب: Özlem KANDEMİR
منشور في: (2018-12-01)

Detection of drug resistance mutations of hepatitis C virus in patients with failure of the treatment with direct acting antivirals
حسب: D. E. Valutite, وآخرون
منشور في: (2021-03-01)

Long term changes in thrombocytopenia and leucopenia after HCV eradication with direct-acting antivirals
حسب: Kazuto Tajiri, وآخرون
منشور في: (2023-05-01)

Identification and Characterization of Antiviral Activity of Synthetic Compounds Against Mayaro Virus
حسب: Ana Paula Andreolla, وآخرون
منشور في: (2025-05-01)

Antiviral activity of myricetin glycosylated compounds isolated from Marcetia taxifolia against chikungunya virus
حسب: Ana Luisa Muñoz, وآخرون
منشور في: (2023-07-01)

Pharmaceutical policies and regulations of oral antiviral drugs for treatment of hepatitis C in Egypt—case study
حسب: Mahmoud H. Teaima, وآخرون
منشور في: (2021-12-01)

Direct-Acting Antiviral Agents in Prevention of Maternal–Fetal Transmission of Hepatitis C Virus in Pregnancy
حسب: Christopher Hartley, وآخرون
منشور في: (2024-06-01)

Effect of direct-acting antivirals on corrected QT interval and cardiac functions in patients with chronic hepatitis C virus infection
حسب: Mohamed Gamal Ibrahim, وآخرون
منشور في: (2020-02-01)

Direct-Acting Antiviral Therapy for Hepatitis C Virus in Patients with BCLC Stage B/C Hepatocellular Carcinoma
حسب: Shou-Wu Lee, وآخرون
منشور في: (2022-10-01)

Treading a HOSTile path: Mapping the dynamic landscape of host cell–rotavirus interactions to explore novel host-directed curative dimensions
حسب: Upayan Patra, وآخرون
منشور في: (2021-12-01)

Efficacy of direct-acting antivirals in patients with hepatitis C virus-associated cryoglobulinemic vasculitis: Results of a long-term follow-up
حسب: S. V. Gavrisheva, وآخرون
منشور في: (2023-04-01)